SARS-CoV-2 Nucleocapsid anticorps
-
- Antigène Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Anticorps
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- Reactivité
- SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta, SARS CoV-2 Delta, SARS CoV-2 Gamma, SARS CoV-2 Omicron, SARS CoV-2 Alpha
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp SARS-CoV-2 Nucleocapsid est non-conjugé
-
Application
- ELISA, Western Blotting (WB), Lateral Flow (LF)
- Fonction
- Monoclonal Antibody to SARS-CoV-2 Nucleocapsid Protein
- Specificité
- This antibody and its recommended antibody pair have been proven to detect all known SARS-CoV-2 variants such as Omicron variant (B1.1.529), Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), and Delta (B.1.617.2). This antibody is used in several regulated immunoassays worldwide.
- Réactivité croisée (Details)
-
This antibody does not cross react with:
- MERS-coronavirus
- Human coronavirus (NL63, 229E, OC43)
- Human Adenovirus (type 1, 3, 5, 7, 8, 11, 18, 23)
- Human Parainfluenza virus (type 1, 2, 3, 4)
- Human Rhinovirus (type 1, 14, 42)
- Human Metapneumovirus
- Respiratory syncytial virus-A
- Respiratory syncytial virus-B
This antibody does cross react with SARS-CoV.
- Attributs du produit
- The performance of a rapid antigen test is limited by the sensitivity of the antibodies used. The new pair of monoclonal antibodies is highly sensitive for the detection of SARS-CoV-2 Nucleoprotein and they do not cross-react with seasonal coronavirus strains. They are ideal for developing reliable and sensitive rapid lateral flow antigen assays for the detection of active COVID-19 infections.
- Purification
- Protein A Chromatography
- Pureté
- > 95 % (SDS-PAGE)
- Immunogène
- Recombinant SARS-CoV-2 Nucleocapsid Protein
- Isotype
- IgG1
- Top Product
- Discover our top product SARS-CoV-2 N Anticorps primaire
-
-
- Indications d'application
-
Each laboratory should determine an optimum working titer for use in its particular application.
Recommended pair for Immunoassay:Capture - Detection
- ABIN6953170 - ABIN6953169
- ABIN6953170 - ABIN6953295
- Commentaires
-
An FDA-approved COVID-19 lateral flow assay using the SARS-CoV-2 nucleocapsid antibody pair (ABIN6953170 + ABIN6953169 ) shows that the pair can detect the Omicron variant (live virus of B.1.1.529) up to 1.31 x 10^2 PFU/mL, and other variants up to 1.88 x 10^2 PFU/mL. The two antibodies recognize the conserved nucleoprotein domain of SARS-CoV-2 and are already used in many commercially available COVID-19 antigen rapid tests around the world.
These two antibodies work as a High-Sensitivity SARS-CoV-2 Nucleoprotein Antibody Pair for Rapid COVID-19 Antigen Assays: ABIN6953170, ABIN6953169
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 4.8 mg/mL
- Buffer
- Phosphate Buffered Saline, pH 7.4, 0.05 % Sodium Azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C
-
- Antigène
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
- Autre désignation
- SARS-CoV-2 Nucleocapsid Protein (SARS-CoV-2 N Produits)
- Synonymes
- anticorps nucleocapsid phosphoprotein, anticorps N
- Classe de substances
- Viral Protein
-